Colorado 2018 Regular Session Status: Enacted

HB 18-1007 — Substance Use Disorder Payment And Coverage

Last action — Governor Signed

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 10, 2018. Enacted.

Prognosis

Likely to advance 76% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 4 sponsors

    4 primary, 0 co-sponsors signed on.

  • Cleared a recorded vote

    Passed 1 recorded vote so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Opioid and Other Substance Use Disorders Interim Study Committee. The bill requires all individual and group health benefit plans to provide coverage without prior authorization for a five-day supply of at least one of the federal food and drug administration-approved drugs for the treatment of opioid dependence for a first request within a 12-month period. The bill prohibits carriers from taking adverse action against a provider or from providing financial incentives or disincentives to a provider based solely on a patient satisfaction survey relating to the patient's satisfaction with pain treatment. The bill clarifies that an 'urgent prior authorization request' to a carrier includes a request for authorization of medication-assisted treatment for substance use disorders. The bill permits a pharmacy that has entered into a collaborative pharmacy practice agreement with one or more physicians to administer injectable antagonist medication for substance use disorders and receive an enhanced dispensing fee for the administration. The bill requires the Colorado medical assistance program to authorize reimbursement for at least one federal food and drug administration-approved ready-to-use opioid overdose reversal drug without prior authorization. The bill permits a pharmacy that has entered into a collaborative pharmacy practice agreement with one or more physicians to administer injectable opioid antagonist medication for substance use disorders and receive an enhanced dispensing fee under the Colorado medical assistance program for the administration. The bill requires the department of health care policy and financing and the office of behavioral health in the department of human services to establish rules that standardize utilization management authority timelines for the nonpharmaceutical components of medication-assisted treatment for substance use disorders. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) Read More

Bill Text

What changed in the latest version

16 added · 20 removed

Plain-language change summary

The recent changes to HB 18-1007 clarify that health benefit plans covering physical therapy, acupuncture, or chiropractic services must treat these services equally to primary care when addressing chronic pain in patients with substance use disorders. Additionally, the bill specifies that individuals can receive a five-day supply of certain approved medications for opioid dependence only once in a year, which helps ensure these resources are used appropriately. These adjustments are important because they aim to improve access to necessary treatments for individuals battling pain and substance use issues, potentially leading to better health outcomes.

→
Previous
Latest
Second Regular Session Seventy-first General Assembly STATE OF COLORADO REENGROSSED This Version Includes All Amendments Adopted in the House of Introduction LLS NO.
Second Regular Session Seventy-first General Assembly STATE OF COLORADO ENGROSSED This Version Includes All Amendments Adopted on Second Reading in the House of Introduction LLS NO.
This summary applies to this bill as introduced and does notreflectanyamendmentsthatmaybesubsequentlyadopted.Ifthisbill e n passes third reading in the house of introduction, a bill summary that m 1 applies to the reengrossed version of this bill will be available at E n 2 U U 0 http://leg.colorado.gov/.) O i i H a p R A Opioid and Other Substance Use Disorders Interim Study r Committee.
This summary applies to this bill as introduced and does notreflectanyamendmentsthatmaybesubsequentlyadopted.Ifthisbill passes third reading in the house of introduction, a bill summary that applies to the reengrossed version of this bill will be available at http://leg.colorado.gov/.) Opioid and Other Substance Use Disorders Interim Study Committee.
The bill requires all individual and group health benefit 3 plans to provide coverage without prior authorization for a five-day supply of buprenorphine for a first request within a 12-month period.
The bill requires all individual and group health benefit plans to provide coverage without prior authorization for a five-day supply of buprenorphine for a first request within a 12-month period.
Additionally, all individual and group health benefit plans that i a 1 cover physical therapy, acupuncture, or chiropractic services shall not E e 2 U d 9 O 2 i Shading denotes HOUSE amendment.
Additionally, all individual and group health benefit plans that i 8 cover physical therapy, acupuncture, or chiropractic services shall not a 0 S R , O n 1 Shading denotes HOUSE amendment.
H d p Capital letters or bold & italic numbers indicate new material to be added to existing statude.
H 2 r Capital letters or bold & italic numbers indicate new material to be added to existing dtatute.
e A subject those services to dollar limits, deductibles, copayments, or coinsurance provisions that are less favorable than those applicable to primarycareservicesundertheplanifthecoveredpersonhasadiagnosis of chronic pain and has or has had a substance use disorder diagnosis.
e m A subject those services to dollar limits, deductibles, copayments, or coinsurance provisions that are less favorable than those applicable to primarycareservicesundertheplanifthecoveredpersonhasadiagnosis of chronic pain and has or has had a substance use disorder diagnosis.
⬇ Download PDF
View plain text versions (8)

Amendments

1 amendment

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Governor Signed

  2. Sent to the Governor

  3. Signed by the President of the Senate

  4. Signed by the Speaker of the House

  5. Senate Third Reading Passed - No Amendments

  6. Senate Second Reading Special Order - Passed - No Amendments

  7. Senate Committee on State, Veterans, & Military Affairs Refer Unamended - Consent Calendar to Senate Committee of the Whole

  8. Introduced In Senate - Assigned to State, Veterans, & Military Affairs

  9. House Third Reading Passed - No Amendments

  10. House Second Reading Special Order - Passed with Amendments - Committee, Floor

  11. House Second Reading Laid Over to 04/19/2018 - No Amendments

  12. House Second Reading Laid Over to 04/17/2018 - No Amendments

  13. House Second Reading Special Order - Laid Over Daily - No Amendments

  14. House Second Reading Laid Over to 04/13/2018 - No Amendments

  15. House Second Reading Laid Over to 04/10/2018 - No Amendments

  16. House Second Reading Laid Over to 04/09/2018 - No Amendments

  17. House Second Reading Laid Over to 04/02/2018 - No Amendments

  18. House Second Reading Laid Over to 03/29/2018 - No Amendments

  19. House Second Reading Laid Over to 03/28/2018 - No Amendments

  20. House Second Reading Laid Over to 03/27/2018 - No Amendments

  21. House Second Reading Laid Over to 03/26/2018 - No Amendments

  22. House Second Reading Special Order - Laid Over to 03/19/2018 - No Amendments

  23. House Committee on Public Health Care & Human Services Refer Amended to House Committee of the Whole

  24. Introduced In House - Assigned to Public Health Care & Human Services

Sponsors

  • Jonathan Singer · Primary
  • Kent Lambert · Primary
  • Cheri Jahn · Primary
  • deGruy Kennedy · Primary

Sponsorship breakdown

Export CSV (upgrade) →

4 sponsors · 0 co-sponsors · 98 not signed on · 1 voted No

Sponsors (4)

Co-sponsors (0)

None.

Not signed on (98)

98 members have not signed on to this bill.

Show all 98 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

BILL

Passed 28 Yea · 5 Nay · 2 Other
Party YeaNayPresentNot Voting
Unaffiliated 27502
Democrat 1000
Total 28502
% of votes cast 80%14%0%6%
How each member voted (35)
Member Party Vote
Court — Yea
Gardner — Yea
Kerr — Yea
Neville T. — Yea
Williams A. — Yea
Aguilar — Yea
Baumgardner — Not Voting
Cooke — Yea
Coram — Yea
Crowder — Yea
Donovan — Yea
Fenberg — Yea
Fields — Yea
Grantham — Yea
Guzman — Yea
Hill — Nay
Holbert — Nay
Jones — Yea
Jahn — Yea
Kagan — Yea
Kefalas — Yea
Lambert — Yea
Lundberg — Yea
Marble — Nay
Merrifield — Yea
Moreno — Yea
Priola — Yea
Scott — Yea
Smallwood — Nay
Sonnenberg — Not Voting
Tate — Yea
Todd — Yea
Zenzinger — Yea
Martinez Humenik — Nay
Lorena Garcia Democrat Yea

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 18-1007 do?
Opioid and Other Substance Use Disorders Interim Study Committee. The bill requires all individual and group health benefit plans to provide coverage without prior authorization for a five-day supply of at least one of the federal food and drug administration-approved drugs for the treatment of opioid dependence for a first request within a 12-month period. The bill prohibits carriers from taking adverse action against a provider or from providing financial incentives or disincentives to a provider based solely on a patient satisfaction survey relating to the patient's satisfaction with pain treatment. The bill clarifies that an 'urgent prior authorization request' to a carrier includes a request for authorization of medication-assisted treatment for substance use disorders. The bill permits a pharmacy that has entered into a collaborative pharmacy practice agreement with one or more physicians to administer injectable antagonist medication for substance use disorders and receive an enhanced dispensing fee for the administration. The bill requires the Colorado medical assistance program to authorize reimbursement for at least one federal food and drug administration-approved ready-to-use opioid overdose reversal drug without prior authorization. The bill permits a pharmacy that has entered into a collaborative pharmacy practice agreement with one or more physicians to administer injectable opioid antagonist medication for substance use disorders and receive an enhanced dispensing fee under the Colorado medical assistance program for the administration. The bill requires the department of health care policy and financing and the office of behavioral health in the department of human services to establish rules that standardize utilization management authority timelines for the nonpharmaceutical components of medication-assisted treatment for substance use disorders. (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.) Read More
Who sponsors HB 18-1007?
HB 18-1007 is sponsored by Jonathan Singer, Kent Lambert, Cheri Jahn, and deGruy Kennedy.
What is the current status of HB 18-1007?
This bill has been enacted into law. Introduced January 10, 2018. Enacted.
Where can I track HB 18-1007?
Track HB 18-1007 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 18-1007

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 18-1007

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →